MedTrace Logo

A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection

NCT04335084 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 254

Last updated 2025-06-05

No results posted yet for this study

Summary

This is a Phase II interventional study testing whether treatment with hydroxychloroquine, Vitamin C, Vitamin D, and Zinc can prevent symptoms of COVID-19

Conditions

  • COVID-19
  • Coronavirus Infection
  • Sars-CoV2
  • Corona Virus Infection
  • COVID
  • Coronavirus
  • Coronavirus-19
  • Coronavirus 19

Interventions

DRUG

Hydroxychloroquine

Prophylaxis treatment for COVID-19

DIETARY_SUPPLEMENT

Vitamin C

Prophylaxis treatment for COVID-19

DIETARY_SUPPLEMENT

Vitamin D

Prophylaxis treatment for COVID-19

DIETARY_SUPPLEMENT

Zinc

Prophylaxis treatment for COVID-19

Sponsors & Collaborators

  • DSCS CRO

    collaborator INDUSTRY

  • ProgenaBiome

    lead OTHER

Principal Investigators

  • Sabine Hazan, MD · ProgenaBiome

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-22
Primary Completion
2022-05-31
Completion
2024-04-11
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04335084 on ClinicalTrials.gov